Dasatinib Tablet
FDA Label NDC 70771-1902

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Dasatinib (NDC 70771-1902). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1901-6

Dasatinib Tablets, 20 mg

60 Tablets

Rx only

Zydus

20 mg (571889d7 845d 4fed 8d7d 6470d4d36fa1 01)

NDC 70771-1902-6

Dasatinib Tablets, 50 mg

60 Tablets

Rx only

Zydus

50 mg (571889d7 845d 4fed 8d7d 6470d4d36fa1 02)

NDC 70771-1903-6

Dasatinib Tablets, 70 mg

60 Tablets

Rx only

Zydus

70 mg (571889d7 845d 4fed 8d7d 6470d4d36fa1 03)

NDC 70771-1904-3

Dasatinib Tablets, 80 mg

30 Tablets

Rx only

Zydus

80 mg (571889d7 845d 4fed 8d7d 6470d4d36fa1 04)

NDC 70771-1905-3

Dasatinib Tablets, 100 mg

30 Tablets

Rx only

Zydus

100 mg (571889d7 845d 4fed 8d7d 6470d4d36fa1 05)

NDC 70771-1906-3

Dasatinib Tablets, 140 mg

30 Tablets

Rx only

Zydus

140 mg (571889d7 845d 4fed 8d7d 6470d4d36fa1 06)

* Please review the disclaimer below.